Home › Graft-Versus-Host Disease › Michigan › Detroit
Graft-Versus-Host Disease clinical trials in Detroit, MI
4 studies for Graft-Versus-Host Disease are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
RecruitingPhase 2
- Barbara Ann Karmanos Cancer Institute, Detroit
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RecruitingPhase 3
- Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis
RecruitingPhase 1
- Henry Ford Hospital, Detroit
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- Henry Ford Cancer Institute, Detroit
Graft-Versus-Host Disease trials in other cities
- Boston, MA10 studies
- New York City, NY7 studies
- Columbus, OH6 studies
- Baldwin Park, CA5 studies
- Atlanta, GA5 studies
- Washington, DC5 studies
- Pittsburgh, PA4 studies
- St. Louis, MO4 studies
- Portland, OR4 studies
- Tampa, FL4 studies
- Seattle, WA4 studies
- Miami, FL4 studies
Other studies in Detroit
- Non-Small Cell Lung Cancer44 studies
- Breast Cancer33 studies
- Cancer (all types)29 studies
- Colorectal Cancer26 studies
- Ovarian Cancer26 studies
- Metastatic Cancer24 studies
- Prostate Cancer22 studies
- Endometrial Cancer21 studies
- Lung Cancer20 studies
- Multiple Myeloma19 studies
- Stomach Cancer16 studies
- Head and Neck Squamous Cell Carcinoma15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.